RecruitingNCT07309848

Hip Fracture Surgery Timing and Blood Transfusion Risk in Patients on DOACs

Blood Transfusion Risk After Early vs. Delayed Surgery in Hip Fracture Patients on Direct Oral Anticoagulants: A Natural Experiment

Sponsor

St. Antonius Hospital

Enrollment

374 participants

Start Date

Nov 1, 2025

Study Type

OBSERVATIONAL

Conditions

blood transfusion Blood Transfusion Complication Bleeding Geriatric Hip Fracture Surgeries Direct Oral Anticoagulants (DOACs)Bleeding Complications Bleeding as Surgical Complication (Treatment)Blood Transfusions

Summary

This study looks at patients with hip fractures who are taking direct oral anticoagulants (DOACs), a type of blood thinner. In many hospitals, surgery for these patients is delayed because of concerns about bleeding, but waiting longer can also increase risks such as complications and longer hospital stays. The purpose of this study is to find out whether operating within 24 hours is as safe as delaying surgery beyond 24 hours. Specifically, the investigators want to know if early surgery does not lead to a higher need for blood transfusions compared to delayed surgery.

Eligibility

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with bleeding, bleeding complications, and other related conditions. The study is currently recruiting participants at 7 locations.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.